Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats
Ziqin Zhao
Abstract
Ziqin Zhao
Abstract
Objective To explore the regulation of telmisartan on expression of peroxisome proliferator-activated receptor(PPAR) 1 and PPARγ2 in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) in high-fat diet fed OLETF rats and their tissue difference.Methods Thirty four-week-old male OLETF rats were selected and 12 gender-and age-matched Long-Evans Tokushima Otsuka(LETO) rats were used as normal control.From 8 weeks of age,the OLETF rats were fed with high-fat diet.At 22 weeks of age,there was no case of impaired glucose tolerance or type 2 diabetes mellitus in OLETF rats tested by oral glucose tolerance test (OGTT).Then,these pre-diabetic OLETF rats were divided into telmisartan group (O-T group,5 mg· kg-1 · d-1,n =10),pioglitazone group (O-P group,10 mg · kg-1 · d-1,n=8),and untreated control group (O-T group,n =10) according to the radom number table.LETO (n =12) rats were used as control group.OGTT was carried out at 48 weeks of age,and homeostasis model assessment of insulin resistance(HOMA-IR)was evaluated.Serum PPARγwas measured using ELISA.The mRNA levels of PPARγ1 and PPARγ2 in different fatty tissues were determined by real-time PCR.The adipocyte sizes were also assessed.Results Compared with O-C group,the PPARγ2 level in SAT was significantly up-regulated in O-T group(P <0.01),while no difference was observed between O-T and O-P group.In addition,both PPARγ1 and PPARγ2 mRNA levels in VAT were up-regulated in O-T group (P <0.01).There was a negative correlation bctween HOMA-IR and PPARγ2 mRNA expression in VAT (ρ =-0.369,P =0.021).Compared with O-C group,the adipose cell size was decreased by 56% in O-T group.Conclusion Telnisartan can at least partially up-regulate the expression of PPARγ,1 and PPARγ2 in SAT and VAT,decrease the adipose cell size,and improve insulin sensitivity by activating PPARγ. Key words: Telmisartan; Type 2 diabetes mellitus; Peroxisome proliferator-activated receptor γ; Adipose tissue
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the regulation of telmisartan on expression of peroxisome proliferator-activated receptor(PPAR) 1 and PPARγ2 in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) in high-fat diet fed OLETF rats and their tissue difference.Methods Thirty four-week-old male OLETF rats were selected and 12 gender-and age-matched Long-Evans Tokushima Otsuka(LETO) rats were used as normal control.From 8 weeks of age,the OLETF rats were fed with high-fat diet.At 22 weeks of age,there was no case of impaired glucose tolerance or type 2 diabetes mellitus in OLETF rats tested by oral glucose tolerance test (OGTT).Then,these pre-diabetic OLETF rats were divided into telmisartan group (O-T group,5 mg· kg-1 · d-1,n =10),pioglitazone group (O-P group,10 mg · kg-1 · d-1,n=8),and untreated control group (O-T group,n =10) according to the radom number table.LETO (n =12) rats were used as control group.OGTT was carried out at 48 weeks of age,and homeostasis model assessment of insulin resistance(HOMA-IR)was evaluated.Serum PPARγwas measured using ELISA.The mRNA levels of PPARγ1 and PPARγ2 in different fatty tissues were determined by real-time PCR.The adipocyte sizes were also assessed.Results Compared with O-C group,the PPARγ2 level in SAT was significantly up-regulated in O-T group(P <0.01),while no difference was observed between O-T and O-P group.In addition,both PPARγ1 and PPARγ2 mRNA levels in VAT were up-regulated in O-T group (P <0.01).There was a negative correlation bctween HOMA-IR and PPARγ2 mRNA expression in VAT (ρ =-0.369,P =0.021).Compared with O-C group,the adipose cell size was decreased by 56% in O-T group.Conclusion Telnisartan can at least partially up-regulate the expression of PPARγ,1 and PPARγ2 in SAT and VAT,decrease the adipose cell size,and improve insulin sensitivity by activating PPARγ. Key words: Telmisartan; Type 2 diabetes mellitus; Peroxisome proliferator-activated receptor γ; Adipose tissue
Key concepts: Internal medicine, Endocrinology, Telmisartan, Adipose tissue, Pioglitazone, Insulin resistance, Medicine, Rosiglitazone